If this is your company, CONTACT US to activate Packbase™ software to build your portal.

    Webpackaging logo

    SGD Pharma shortlisted for the CPhI Pharma Awards

    Quick Contact
    • SGD Pharma
    SGD Pharma shortlisted for the CPhI Pharma Awards
    Health, Pharmaceuticals, Primary Packaging, Bottles, Bottles - Glass, Shows, Associations, Media, Packaging Trade Shows, Events, CPhI, Packaging Awards

    We are thrilled to announce that SGD Pharma has been shortlisted as a finalist in the Packaging category for the CPhI Pharma Awards 2018.

    The Awards celebrate thinkers and creators breaking new ground and strongly advocate companies committed to driving the industry forward.

    This year, SGD Pharma presents its exciting new product: Clareo. The finalists have been chosen among 250 participants.

    This glittering event will take place on 9th October 2018 at the Eurostars Madrid Tower.

    See also

    SGD Pharma launches industry first ready-to-use sterile 100 ml molded glass vials in SG EZ-fill packaging technology

    Worldwide glass primary packaging supplier SGD Pharma has announced the introduction of its 100H ml Ready-to-Use (RTU) Type I molded glass vials for aseptic fill/finish of parenteral drug products. The addition of 100 ml molded glass vials to the Sterinity platform is pioneering, with SGD Pharma being the first global molded glass manufacturing company to offer this size of solution in the RTU market.

    SGD Pharma speeds up time to market with industry first Ready-to-Use Nest & Tub packaging solution for molded glass vials

    Increased demand for parenteral drugs generated by the Covid-19 pandemic has resulted in additional pressures being placed on biopharmaceutical companies to accelerate their time-to-market. This new RTU primary and secondary packaging combination from SGD Pharma offers biopharmaceutical producers the flexibility they need to deliver innovative medicines to patients significantly faster.

    SGD Pharma upgrades its Chinese plant toward an automated and improved production

    SGD Pharma's Zhanjiang (China) plant produces 1.2 million Type II & III flint molded glass vials daily for the parenteral market and for health care beauty products. With a surface of ​​85,000m2, the plant included a glass furnace, 6 production lines, an ISO 8 clean room of 2000m2, a resorting room and a customization workshop. In early 2018, SGD Pharma invested 7 million Euros to improve the automation and the production, including the rebuilding of the furnace, to make the plant an exemplary production center.

    • Company News
    • English
    • Modified 02 Oct 2018
    • Hits 736
    Axium Packaging
    Adequate Packaging
    NF Beauty Group